PSMA
The new prostate-specific membrane antigen (PSMA) PET imaging will significantly improve the detection and treatment of prostate cancer. The FDA approved the drug for positron emission tomography (PET) imaging of PSMA-positive lesions in men with prostate cancer. 68Ga-PSMA-11 is a radioactive imaging agent that binds to prostate cancer cells to help locate prostate cancer cells.
-
- Class: Class II
- Antigen: PSMA
- Antigen Species: Human
- Peptide: NYTLRVDCTPLMYSL
- Conjugate: APC
Compare
-
- Class: Class II
- Antigen: PSMA
- Antigen Species: Human
- Peptide: NYTLRVDCTPLMYSL
- Conjugate: BV421
Compare
-
- Class: Class II
- Antigen: PSMA
- Antigen Species: Human
- Peptide: NYTLRVDCTPLMYSL
Compare
-
- Class: Class II
- Antigen: PSMA
- Antigen Species: Human
- Peptide: NYTLRVDCTPLMYSL
- Conjugate: PE
Compare
-
- Class: Class II
- Antigen: PSMA
- Antigen Species: Human
- Peptide: NYTLRVDCTPLMYSL
- Conjugate: FITC
Compare
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.